Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Royal Bank of Canada theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) CMO Pushkal Garg sold 3,461 shares of the stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $185.85, for a total transaction of $643,226.85. Following the sale, the chief marketing officer now owns 8,511 shares in the […]
Royal Bank of Canada restated their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note published on Friday morning, Benzinga reports. The brokerage currently has a $270.00 price objective on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. StockNews.com raised Alnylam Pharmaceuticals from a […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They currently have a $240.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s target price points to a potential upside of 28.51% from […]
StockNews.com began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on ALNY. Canaccord Genuity Group lowered their price target on Alnylam Pharmaceuticals from $310.00 to […]